يعرض 1 - 19 نتائج من 19 نتيجة بحث عن '"Mom, CH"', وقت الاستعلام: 0.48s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
  6. 6
    Conference
  7. 7
    Conference
  8. 8
    Conference
  9. 9
    Conference
  10. 10
    Academic Journal

    المصدر: Heeren , AM , Rotman , J , Stam , A G M , Pocorni , N , Gassama , A , Samuels , S , Bleeker , M C G , Mom , CH , Zijlmans , H J M A A , Kenter , GG , Jordanova , ES & de Gruijl , TD 2019 , ' Efficacy of PD-1 blockade in cervical cancer is related to a CD8+FoxP3+CD25+ T-cell subset with operational effector functions despite high immune checkpoint levels ' , Journal for Immunotherapy of Cancer , vol. 7 , no. 1 , 43 . https://doi.org/10.1186/s40425-019-0526-z

  11. 11
  12. 12
    Academic Journal

    المصدر: Wollinga , TX , Ezendam , NPM , Eggink , FA , Smink , M , van Hamont , D , Pijlman , B , Boss , E , Robbe , EJ , Ngo , H , Boll , D , Mom , CH , van der Aa , MA , Kruitwagen , R , Nijman , HW & Pijnenborg , JMA 2018 , ' Implementation of laparoscopic hysterectomy for endometrial cancer over the past decade ' , Gynecological Surgery , vol. 15 , Unsp 7 . https://doi.org/10.1186/s10397-018-1040-x

    وصف الملف: application/pdf

  13. 13
    Conference
  14. 14
    Conference
  15. 15
    Academic Journal

    المصدر: Rouvroye , MD , Tack , GJ , Mom , CH , Lissenberg-Witte , BI , Pierik , MJ , Neefjes-Borst , EA , van der Woude , C J , van Tuyl , S & van Bodegraven , AA 2020 , ' Vulvar and vaginal neoplasia in women with inflammatory bowel disease ' , Digestive and Liver Disease , vol. 52 , no. 2 , pp. 149-155 . https://doi.org/10.1016/j.dld.2019.10.002

  16. 16
    Academic Journal
  17. 17
    Conference
  18. 18
    Academic Journal
  19. 19
    Academic Journal

    المصدر: Eskens , F , Mom , CH , Planting , AST , Gietema , JA , Amelsberg , A , Huisman , H , van Doorn , L , Burger , H , Stopfer , P , Verweij , J & Vries , E 2008 , ' A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor I (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours ' , British Journal of Cancer , vol. 98 , no. 1 , pp. ....